Shin‐ichiro Mori

1.0k citations

39 papers · 714 indexed · h-index 15

Hematology top 2%
- Hematopoietic Stem Cell Transplantation 20
- Acute Myeloid Leukemia Research 8
- Platelet Disorders and Treatments 3
Transplantation top 10%
Genetics top 10%
- Mesenchymal stem cell research 4
Immunology
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 6
Oncology
- Neutropenia and Cancer Infections 4
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 5

Co-authors: Yoichi Takaue Ryuji Tanosaki Yuji Heike Sung Won Kim Takahiro Fukuda Shigeo Fuji Kensei Tobinai Ken Shortman
Cited by: Hematology Transplantation Genetics
Journals: Proceedings of the National Academy of Sciences (1 paper)Blood (11 papers)International Journal of Cancer (1 paper)
Partner nations: Japan United States Australia

In The Last Decade

Shin‐ichiro Mori

37 papers receiving 700 citations

Peers

Countries citing papers authored by Shin‐ichiro Mori

Since Specialization

Citations

This map shows the geographic impact of Shin‐ichiro Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin‐ichiro Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin‐ichiro Mori more than expected).

Fields of papers citing papers by Shin‐ichiro Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin‐ichiro Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin‐ichiro Mori. The network helps show where Shin‐ichiro Mori may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shin‐ichiro Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shin‐ichiro Mori Line = papers co-authored together Shin‐ichiro Mori links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program Transplantation and Cellular Therapy ·Yoshinobu Kanda,Masami Inoue,Naoyuki Uchida,Yasushi Onishi,Reiko Kamata,Mika Kotaki,Ryōji Kobayashi,Junji Tanaka,Takahiro Fukuda,Nobuharu Fujii,Koichi Miyamura,Shin‐ichiro Mori,Yasuo Mori,Yasuo Morishima,Hiromasa Yabe,Yoshihisa Kodera	2021	10
2	Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens International Journal of Hematology ·Satoshi Yamasaki,Akiko Miyagi‐Maeshima,Yasuo Kakugawa,Yoshihiro Matsuno,Fusako Ohara-Waki,Shigeo Fuji,Yuriko Morita‐Hoshi,Masakazu Mori,Sung Won Kim,Shin‐ichiro Mori,Takahiro Fukuda,Ryuji Tanosaki,Tadakazu Shimoda,Kensei Tobinai,Daizo Saito,Yoichi Takaue,Takanori Teshima,Yuji Heike	2013	1
3	An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP) International Journal of Hematology ·Yukari Shirasugi,Kiyoshi Ando,Kôji Miyazaki,Yoshiaki Tomiyama,Koji Iwato,Shinichiro Okamoto,Mineo Kurokawa,Keita Kirito,Satoshi Hashino,Haruhiko Ninomiya,Shin‐ichiro Mori,Yuji Yonemura,Kensuke Usuki,Helen Wei,Richard Lizambri	2012	33
4	Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial International Journal of Hematology ·Yukari Shirasugi,Kiyoshi Ando,Kôji Miyazaki,Yoshiaki Tomiyama,Shinichiro Okamoto,Mineo Kurokawa,Keita Kirito,Yuji Yonemura,Shin‐ichiro Mori,Kensuke Usuki,Koji Iwato,Satoshi Hashino,Helen Wei,Richard Lizambri	2011	90
5	Possible Association between Obesity and Posttransplantation Complications Including Infectious Diseases and Acute Graft-versus-Host Disease Biology of Blood and Marrow Transplantation ·Shigeo Fuji,Sung Won Kim,Ken-ichi Yoshimura,Hideki Akiyama,Shin-ichiro Okamoto,Hiroshi Sao,Junko Takita,Naoki Kobayashi,Shin‐ichiro Mori	2009	42
6	Impact of T Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen Biology of Blood and Marrow Transplantation ·Bungo Saito,Takahiro Fukuda,Hiroki Yokoyama,Saiko Kurosawa,Toshihiro Takahashi,Shigeo Fuji,Noriko Takahashi,Kinuko Tajima,Sung Won Kim,Shin‐ichiro Mori,Ryuji Tanosaki,Yoichi Takaue,Yuji Heike	2008	39
7	Isolated granulocytic sarcoma of the small intestine successfully treated with chemotherapy and bone marrow transplantation International Journal of Hematology ·Yukiko Kitagawa,Yuichi Sameshima,Hiroko Shiozaki,Shinpei Ogawa,Akihiro Masuda,Shin‐ichiro Mori,Masanao Teramura,Michihiko Masuda,Shingo Kameoka,Toshiko Motoji	2008	23
8	Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Shigeo Fuji,Sung Won Kim,Takahiro Fukuda,Shin‐ichiro Mori,Satoshi Yamasaki,Yuriko Morita‐Hoshi,Fusako Ohara-Waki,Yuji Heike,Kensei Tobinai,Ryuji Tanosaki,Yoichi Takaue	2008	51
9	Comparable Antileukemia/Lymphoma Effects in Nonremission Patients Undergoing Allogeneic Hematopoietic Cell Transplantation with a Conventional Cytoreductive or Reduced-Intensity Regimen Biology of Blood and Marrow Transplantation ·Dai Maruyama,Takahiro Fukuda,Ruri Kato,Satoshi Yamasaki,Eiji Usui,Yuriko Morita‐Hoshi,Sung Won Kim,Shin‐ichiro Mori,Yuji Heike,Atsushi Makimoto,Kinuko Tajima,Ryuji Tanosaki,Kensei Tobinai,Yoichi Takaue	2007	23
10	T-Cell Large Granular Lymphocyte Leukemia of Donor Origin After Cord Blood Transplantation Clinical Lymphoma & Myeloma ·Shigeru Kusumoto,Shin‐ichiro Mori,Kisato Nosaka,Yuriko Morita‐Hoshi,Yasushi Onishi,Sung Won Kim,Takashi Watanabe,Yuji Heike,Ryuji Tanosaki,Yoichi Takaue,Kensei Tobinai	2007	9
11	Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation International Journal of Hematology ·Yasushi Onishi,Shin‐ichiro Mori,Shigeru Kusumoto,Kyoko Sugimoto,Daigo Akahane,Yuriko Morita‐Hoshi,Sung Won Kim,Takahiro Fukuda,Yuji Heike,Ryuji Tanosaki,Kensei Tobinai,Yoichi Takaue	2007	10
12	Hematopoietic Cell Transplantation (HCT) for Chemoradiotherapy-Related Myelodysplastic Syndrome and Acute Leukemia: A Single-Center Analysis of 47 Patients. Blood ·Hiroki Yokoyama,Takahiro Fukuda,Yukio Kobayashi,Sung‐Won Kim,Dai Maruyama,Shin‐ichiro Mori,Takashi Watanabe,Ryuji Tanosaki,Kinuko Tajima,Kensei Tobinai,Yoichi Takaue	2007	1
13	Nutritional support for patients suffering from intestinal graft‐versus‐host disease after allogeneic hematopoietic stem cell transplantation American Journal of Hematology ·Osamu Imataki,Shigetoshi Nakatani,Terumi Hasegawa,Miki Kondo,Kiyoko Ichihashi,M. Araki,Toshihiko Ishida,Sung‐Won Kim,Shin‐ichiro Mori,Takahiro Fukuda,Kensei Tobinai,Ryuji Tanosaki,Atsushi Makimoto,Yoichi Takaue	2006	15
14	Monitoring of WT1‐specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation International Journal of Cancer ·Yuriko Morita,Yuji Heike,Mami Kawakami,Osamu Miura,Shin‐ichi Nakatsuka,Michiko Ebisawa,Shin‐ichiro Mori,Ryuji Tanosaki,Takahiro Fukuda,Sung‐Won Kim,Kensei Tobinai,Yoichi Takaue	2006	31
15	Use of hydroxy‐methyl‐glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies Cancer Science ·Hiroshi Iwata,Keitaro Matsuo,Shigeo Hara,Kengo Takeuchi,Tomonori Aoyama,Naoko Murashige,Yoshinobu Kanda,Shin‐ichiro Mori,Ritsuro Suzuki,Shintaro Tachibana,Masaaki Yamane,Masato Odawara,Yoshitomo Mutou,Masahiro Kami	2006	23
16	A Retrospective Single Institute Analysis of 127 Lymphoma Patients Who Underwent Allogeneic Stem Cell Transplantation: Impact on Peripheral T-Cell Lymphoma (PTCL) Including ATLL. Blood ·Ryuji Tanosaki,Sung‐Won Kim,Satoshi Yamazaki,Takahiro Fukuda,Shin‐ichiro Mori,Yuji Heike,Kensei Tobinai,Yoichi Takaue	2006	3
17	Expansion of α-Galactosylceramide-Stimulated Vα24+ NKT Cells Cultured in the Absence of Animal Materials Journal of Immunotherapy ·Yukie Harada,Osamu Imataki,Yuji Heike,Hiroyuki Kawai,Akihiro Shimosaka,Shin‐ichiro Mori,Masahiro Kami,Ryuji Tanosaki,Yoshinori Ikarashi,Akira Iizuka,Mitsuji Yoshida,Hiro Wakasugi,Shigeru Saito,Yoichi Takaue,Masao Takei,Tadao Kakizoe	2005	10
18	Comparative analysis of clinical outcomes after allogeneic bone marrow transplantationversusperipheral blood stem cell transplantation from a related donor in Japanese patients British Journal of Haematology ·Tetsuya Tanimoto,Takuhiro Yamaguchi,Yuji Tanaka,Akiko Saito,Kinuko Tajima,Takahiro Karasuno,Masanobu Kasai,Kenji Kishi,Takehiko Mori,Nobuo Maseki,Satoko Morishima,Shigesaburo Miyakoshi,Masaharu Kasai,Yuju Ohno,Sungwon Kim,Akihiko Numata,Masahiro Kami,Yoichi Takaue,Shin‐ichiro Mori,Mine Harada	2004	27
19	Clinical Significance of Positive Clostridium Difficile (CD) Toxin in the Stool of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Blood ·Yoshiki Terada,Yasushi Onishi,Sung‐Won Kim,Masahiro Kami,Shin‐ichiro Mori,Yuji Heike,Yoichi Takaue,Ryuji Tanosaki	2004	3
20	[Idiopathic interstitial pneumonia that responded to intermittent intravenous administration of high-dose cyclophosphamide]. PubMed ·Shin‐ichiro Mori,Hidetomo Hukunaga,H Iwami,Toshio Takaoka,Yoshihusa Koreeda,Yasunobu Hirotsu,Masaharu Kawabata,Ikuro Maruyama,Mitsuhiro Osame	1994	1

About Shin‐ichiro Mori

Shin‐ichiro Mori is a scholar working on Hematology, Genetics and Transplantation, having authored 39 papers that have together received 714 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (8 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Mesenchymal stem cell research (4 papers), Neutropenia and Cancer Infections (4 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Hematology (464 citations), Transplantation (29 citations) and Genetics (97 citations). Shin‐ichiro Mori has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Yoichi Takaue, Ryuji Tanosaki, Yuji Heike, Sung Won Kim, Takahiro Fukuda, Shigeo Fuji, Kensei Tobinai, Ken Shortman, Li Wu and Yuriko Morita‐Hoshi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact